James Darecca - Chief Financial Officer at TherapeuticsMD, Inc.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
TXMD on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by James Darecca since 20 Sep 2025

Reported holdings for James Darecca in TherapeuticsMD, Inc.

Form 4 holding Chief Financial Officer

TherapeuticsMD, Inc.

Security class
Restricted Stock Units
Shares / value
434,333
Estimated value
$1,580,147
Report date
10 Aug 2021
Price
$3.64
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

TherapeuticsMD, Inc.

Security class
Common Stock
Shares / value
123,830
Estimated value
$277,255
Report date
12 Aug 2021
Price
$2.24
Ownership
Direct

Transaction history for James Darecca in TherapeuticsMD, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .